San Francisco startup Composition Therapeutics can also be working on an oral, when-everyday GLP-1 drug called GSBR-1290—the drug surpassed Wall Avenue’s anticipations in June each time a mid-stage research confirmed normal weight loss of all-around 6% and it strategies to begin A di